SEC Form 4 · accession 0001179110-19-003472
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Meanwell
Officer — Chief Innovation Officer · Director
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 6:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2019 | F | 3,063 | $25.53 | D | 299,663 | D | |
| Common StockF2 | Mar 4, 2019 | F | 3,586 | $25.53 | D | 296,077 | D | |
| Common StockF3 | Mar 4, 2019 | F | 2,962 | $25.53 | D | 293,115 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of common stock were withheld for payment of taxes in connection with the vesting of 9,775 shares of restricted stock from previously reported grant.
- F2Shares of common stock were withheld for payment of taxes in connection with the vesting of 11,350 shares of restricted stock from previously reported grant.
- F3Shares of common stock were withheld for payment of taxes in connection with the vesting of 8,539 shares of restricted stock from previously reported grant.